Summit Cancer Care-Candler
Savannah, Georgia, United States
Cancer treatment center in Savannah, Georgia
225 Candler Dr, Savannah, GA 31405
About Summit Cancer Care-Candler
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
19
Alliance for Clinical Trials in Oncology
7
SWOG Cancer Research Network
7
ECOG-ACRIN Cancer Research Group
4
NRG Oncology
1
Wake Forest University Health Sciences
1
Clinical Trials at Summit Cancer Care-Candler
During the past decade, Summit Cancer Care-Candler conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 13 clinical trials were completed, i.e. on
average, 36.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
2014-07-22
2023-12-31
Active, not recruiting
280
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
2015-09-10
2033-06-30
Recruiting
600
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
2015-03-25
2023-06-15
Active, not recruiting
174
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
2015-04-29
2031-03-29
Active, not recruiting
415
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Summit Cancer Care-Candler" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials
sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NRG Oncology"
with 4 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Summit Cancer Care-Candler"
#1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Summit Cancer Care-Candler
According to Clinical.Site data, the most researched conditions in "Summit Cancer Care-Candler" are
"Breast Carcinoma" (3 trials), "Primary Peritoneal High Grade Serous Adenocarcinoma" (3 trials), "Clinical Stage III Cutaneous Melanoma AJCC v8" (2 trials), "Clinical Stage IV Cutaneous Melanoma AJCC v8" (2 trials) and "Endometrioid Adenocarcinoma" (2 trials). Many other conditions were trialed in "Summit Cancer Care-Candler" in a lesser frequency.
Clinical Trials Intervention Types at Summit Cancer Care-Candler
Most popular intervention types in "Summit Cancer Care-Candler" are "Other" (25 trials), "Drug" (23 trials), "Biological" (18 trials), "Procedure" (16 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Computed Tomography" (12 trials), "Laboratory Biomarker Analysis" (12 trials), "Biospecimen Collection" (11 trials), "Nivolumab" (9 trials) and "Quality-of-Life Assessment" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Summit Cancer Care-Candler
The vast majority of trials in "Summit Cancer Care-Candler" are
34 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at Summit Cancer Care-Candler
Currently, there are NaN active trials in "Summit Cancer Care-Candler".
undefined are not yet recruiting,
7 are recruiting,
25 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Summit Cancer Care-Candler,
1 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Summit Cancer Care-Candler, 2 "Phase 1"
clinical trials were conducted, 20 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".